5-MeO-DALT
From Wikipedia, the free encyclopedia
| 5-MeO-DALT | |
|---|---|
| Chemical name | N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine |
| Chemical formula | C17H22N2O |
| Molecular mass | 270.375 g/mol |
| Melting point | ?? |
| CAS numbers | ?? |
| SMILES | COc2ccc1ncc(CCN(CC=C)CC=C)c1c2 |
5-MeO-DALT (N,N-diallyl-5-methoxytryptamine) is a psychedelic tryptamine believed to be first synthesized by Alexander Shulgin.
Contents |
The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is very closely related to the compound 5-MeO-DPT and DALT.
5-MeO-DALT is usually taken orally at dosages of 12-25mg.
5-MeO-DALT produces rapid, intense entheogenic effects, and it is very short-acting; effects are usually over within 2-4 hours. According to many users, the compound is said to be completely void of visual/hallucinogenic activity, unlike other closely related substances.
There have been no reported deaths or hospitalizations from 5-MeO-DALT, but its safety profile is unknown.
5-MeO-DALT is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-DALT could be prosecuted under the Federal Analog Act because of its structural similarities to other Schedule I substances.
4-Acetoxy-DET | 4-Acetoxy-DIPT | 4-Acetoxy-DMT | 4-HO-DIPT | 5-MeO-α-ET | 5-MeO-α-MT | 5-MeO-DALT | 5-MeO-DET | 5-MeO-DIPT | 5-MeO-DMT | 5-MeO-DPT | 5-MeO-MIPT | α-ET | α-MT | Baeocystin | Bufotenin | DET | DIPT | DMT | DPT | Ethocybin | EIPT | Ethocin | Ibogaine | Iprocin | MET | MIPT | Miprocin | Melatonin | NMT | Norbaeocystin | Psilocin | Psilocybin | Rizatriptan | Serotonin | Sumatriptan | Tryptamine | Tryptophan